Krebs Biochemicals and Industries Limited — Others, 09-04-2026: Disclosure under SEBI Takeover Regulations

Avinash Ravi For and on behalf of Dr. R.T. Ravi Mrs. Hemalata Ravi Mr. Avinash Ravi Mr. Aditya Ravi Mr. Ajay Ravi has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.